Terms: = Liver cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Prognosis
37 results:
1. γδ T Cells: A Game Changer in the Future of Hepatocellular carcinoma Immunotherapy.
Papadakos SP; Arvanitakis K; Stergiou IE; Koutsompina ML; Germanidis G; Theocharis S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338658
[TBL] [Abstract] [Full Text] [Related]
2. Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted car T-cell therapy: a case report.
Wang Y; Zhao Y; Li M; Hou H; Jian Z; Li W; Li P; Ma F; Liu M; Liu H; Xue H
Front Immunol; 2023; 14():1180001. PubMed ID: 37256142
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative Inflammatory Markers in liver Resection for Colorectal liver Metastases: A National Registry-Based Study.
Sahakyan MA; Brudvik KW; Angelsen JH; Dille-Amdam RG; Sandvik OM; Edwin B; Nymo LS; Lassen K
World J Surg; 2023 Sep; 47(9):2213-2220. PubMed ID: 37140610
[TBL] [Abstract] [Full Text] [Related]
4. Thioredoxin facilitates hepatocellular carcinoma stemness and metastasis by increasing BACH1 stability to activate the AKT/mTOR pathway.
Wang C; Zhang L; Cao M; Fu Z; Wang H; Zhang S; Zhu K; Hou Z; Cui J; Yue P; Guo H; Zhang T
FASEB J; 2023 Jun; 37(6):e22943. PubMed ID: 37104068
[TBL] [Abstract] [Full Text] [Related]
5. Development of Engineered car T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic Cholangiocarcinoma.
Mao L; Su S; Li J; Yu S; Gong Y; Chen C; Hu Z; Huang X
J Immunother; 2023 Apr; 46(3):89-95. PubMed ID: 36883998
[TBL] [Abstract] [Full Text] [Related]
6. Lymphocyte-to-C-Reactive Protein Ratio Predicts prognosis in Patients With Colorectal liver Metastases Post-hepatic Resection: A Retrospective Study.
Utsumi M; Inagaki M; Kitada K; Tokunaga N; Kondo M; Yunoki K; Sakurai Y; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
Anticancer Res; 2022 Oct; 42(10):4963-4971. PubMed ID: 36191973
[TBL] [Abstract] [Full Text] [Related]
7. The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by car-T cell immunotherapy.
Guizhen Z; Guanchang J; Liwen L; Huifen W; Zhigang R; Ranran S; Zujiang Y
Front Endocrinol (Lausanne); 2022; 13():918869. PubMed ID: 36093115
[TBL] [Abstract] [Full Text] [Related]
8. Single-cell RNA-Seq reveals the potential risk of anti-mesothelin car T Cell therapy toxicity to different organs in humans.
Wen L; Huang Y; Peng L; Zhao K; Sun Y; Lin Z; Chen Y; Li Z; Qian Q; Tong F; Zhang R; Dong X
Front Immunol; 2022; 13():807915. PubMed ID: 36059490
[TBL] [Abstract] [Full Text] [Related]
9. C-reactive protein/albumin ratio and Glasgow prognostic score are associated with prognosis and infiltration of Foxp3+ or CD3+ lymphocytes in colorectal liver metastasis.
Kanno H; Hisaka T; Akiba J; Hashimoto K; Fujita F; Akagi Y
BMC Cancer; 2022 Aug; 22(1):839. PubMed ID: 35915403
[TBL] [Abstract] [Full Text] [Related]
10. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
[TBL] [Abstract] [Full Text] [Related]
11. car-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
Antonucci L; Canciani G; Mastronuzzi A; Carai A; Del Baldo G; Del Bufalo F
Front Immunol; 2022; 13():867154. PubMed ID: 35603195
[TBL] [Abstract] [Full Text] [Related]
12. Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling.
Li Z; Kwon SM; Li D; Li L; Peng X; Zhang J; Sueyoshi T; Raufman JP; Negishi M; Wang XW; Wang H
J Biol Chem; 2022 May; 298(5):101885. PubMed ID: 35367211
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2.
Xie M; Sun M; Ji X; Li D; Chen X; Zhang B; Huang W; Zhang T; Wang Y; Tian D; Xia L
Theranostics; 2022; 12(3):1097-1116. PubMed ID: 35154476
[No Abstract] [Full Text] [Related]
14. Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.
Matsumoto T; Kitano Y; Imai K; Kinoshita S; Sato H; Shiraishi Y; Mima K; Hayashi H; Yamashita YI; Baba H
Surg Today; 2022 Jul; 52(7):1008-1015. PubMed ID: 35083547
[TBL] [Abstract] [Full Text] [Related]
15. The Landscape Of Alpha Fetoprotein In Hepatocellular carcinoma: Where Are We?
Hu X; Chen R; Wei Q; Xu X
Int J Biol Sci; 2022; 18(2):536-551. PubMed ID: 35002508
[TBL] [Abstract] [Full Text] [Related]
16. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
[TBL] [Abstract] [Full Text] [Related]
17. Immunotherapy for Hepatocellular carcinoma: Current Status and Future Prospects.
Liu Z; Liu X; Liang J; Liu Y; Hou X; Zhang M; Li Y; Jiang X
Front Immunol; 2021; 12():765101. PubMed ID: 34675942
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal liver Metastasis Undergoing Curative Resection.
Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
[No Abstract] [Full Text] [Related]
19. Immunodiagnostic Biomarkers for Hepatocellular carcinoma (HCC): The First Step in Detection and Treatment.
Xing M; Wang X; Kiken RA; He L; Zhang JY
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200243
[TBL] [Abstract] [Full Text] [Related]
20. BACH1 is transcriptionally inhibited by TET1 in hepatocellular carcinoma in a microRNA-34a-dependent manner to regulate autophagy and inflammation.
Sun X; Zhu H; Cao R; Zhang J; Wang X
Pharmacol Res; 2021 Jul; 169():105611. PubMed ID: 33878446
[TBL] [Abstract] [Full Text] [Related]
[Next]
